Apyx Medical reports Renuvion study showing 30% elastin increase and 34% inflammation reduction at Day 180

Apyx Medical Corp

Study published in Plastic and Reconstructive Surgery — Global Open evaluated Renuvion helium plasma RF on skin quality; n=6 completed Day 180.
Treated tissue showed 30% increase in elastin fiber density and 55% increase in elastin staining intensity vs control.
Treated tissue had 34% reduction in inflammation and 27% increase in elastin expression incidence vs untreated control.
100% of participants reported improvement, satisfaction, and would recommend; 100% showed physician- and patient-assessed aesthetic improvement.
CEO Charlie Goodwin said findings support Renuvion's biological basis and that Renuvion should be part of every liposuction procedure.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.